SFX by Ex Libris Inc.

Title:	Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome
Source:	Nature [0028-0836] Liu, G H yr:2011

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Zhang, J. "A Human iPSC Model of Hutchinson Gilford Progeria Reveals Vascular Smooth Muscle and Mesenchymal Stem Cell Defects." Cell stem cell 8.1 (2011): 31-45.
description	2.	Pollex, R L L. "Hutchinson-Gilford progeria syndrome." Clinical genetics 66.5 (2004): 375-81.
description	3.	Gordon, Leslie B. "Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome." Proceedings of the National Academy of Sciences of the United States of America 109.41 (2012): 16666-16671.
description	4.	Harten, Ingrid A. "Age-Dependent Loss of MMP-3 in Hutchinson-Gilford Progeria Syndrome." The journals of gerontology. Series A, Biological sciences and medical sciences 66A.11 (2011): 1201-1207.
description	5.	Ruiz, S. "A High Proliferation Rate Is Required for Cell Reprogramming and Maintenance of Human Embryonic Stem Cell Identity." Current biology 21.1 (2010): 45-52.
description	6.	Eriksson, M. "Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome." Nature 423.6937 (2003): 293-298.
description	7.	Mounkes, Leslie C. "Aging and nuclear organization: lamins and progeria." Current opinion in cell biology 16.3 (2004): 322-7.
description	8.	Glynn, Michael W W. "Incomplete processing of mutant lamin A in Hutchinson–Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition." Human molecular genetics 14.20 (2005): 2959-2969.
description	9.	Kieran, Mark W. "Impact of farnesylation inhibitors on survival in hutchinson-gilford progeria syndrome." Circulation 130.1 (2014): 27-34.
description	10.	Gordon, Leslie B. "Progeria: Translational insights from cell biology." The Journal of cell biology 199.1 (2012): 9-13.
description	11.	Agarwal, Uma S. "Hutchinson-Gilford progeria syndrome." Indian Journal of Dermatology, Venereology and Leprology 76.5 (2010): 591-591.
description	12.	Akter, R. "Effect of lamin A C knockdown on osteoblast differentiation and function." Journal of bone and mineral research 24.2 (2009): 283-93.
description	13.	Plasilova, M. "Homozygous missense mutation in the lamin A C gene causes autosomal recessive Hutchinson-Gilford progeria syndrome." Journal of medical genetics 41.8 (2004): 609-14.
description	14.	Couzin Frankel, J. "Medicine. Drug trial offers uncertain start in race to save children with progeria." Science 337.6102 (2012): 1594-1595.
description	15.	Kelley, Joshua B. "The Defective Nuclear Lamina in Hutchinson-Gilford Progeria Syndrome Disrupts the Nucleocytoplasmic Ran Gradient and Inhibits Nuclear Localization of Ubc9." Molecular and cellular biology 31.16 (2011): 3378-3395.
description	16.	Kawamura, T. "Linking the p53 tumour suppressor pathway to somatic cell reprogramming." Nature 460.7259 (2009): 1140-4.
description	17.	Kieran, Monica W. "New Approaches to Progeria." Pediatrics 120.4 (2007): 834-41.
description	18.	Coleman, Cynthia M. "Mesenchymal stem cells and osteoarthritis: remedy or accomplice?" Human gene therapy 21.10 (2010): 1239-1250.
description	19.	Mohamed Riyaz, S S S. "Progeria." Indian journal of dental research 20.4 (2009): 508-510.
description	20.	Varela, I. "Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging." Nature medicine 14.7 (2008): 767-772.